跳至主要内容
临床试验/NCT07775638
NCT07775638尚未招募不适用

Detecting Liver Fibrosis in Patients At-risk

Helse Stavanger HF1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,200
试验地点
1
主要终点
Diagnostic accuracy of non-invasive diagnostic algorithms for identification of advanced liver fibrosis

研究概览

简要总结

The project will establish a research cohort (called STELIR; STEatotisk Liver-risk In Rogaland) based on a biobank with an associated health register. The purpose is to collect, store and analyze biological material and clinical data from people at risk of steatotic liver disease (fatty liver disease). The research cohort will consist of individuals who agree to participate and will be followed over many years with planned examinations/tests at baseline, after 2 years, after 5 years and every 5 years thereafter. The STELIR cohort consists of individuals between 40 and 70 years of age who have one or more of the following risk factors: Obesity, type 2 diabetes or hazardous or harmful alcohol consumption.

The biological material and clinical data collected will be stored and used for research on liver-related disease risk, diagnostics and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 40 to 70 years at the time of inclusion
  • At least one of the following risk factors: Overweight or obesity, type 2 diabetes mellitus, risky or harmful alcohol consumption
  • Ability to provide written informed consent

排除标准

  • Inability to give informed consent
  • Individuals outside the defined age range
  • Other conditions precluding participation based on investigator assessment

研究组 & 干预措施

STELIR Cohort

Participants enrolled in the STELIR (STEatotic LIver Risk in Rogaland) cohort will be followed longitudinally as part of an observational research biobank. The cohort includes adults at increased risk of steatotic liver disease based on predefined metabolic and lifestyle risk factors.

No intervention is assigned. Participants undergo standardized clinical assessments and biological sample collection as part of routine study procedures.

干预措施: Routine study procedure (Other)

结局指标

主要结局

Diagnostic accuracy of non-invasive diagnostic algorithms for identification of advanced liver fibrosis

时间窗: Baseline

Area under the receiver operating characteristic curve (AUROC) of non-invasive diagnostic algorithms (combinations of clinical variables, blood-based biomarkers, and liver elastography) for identification of advanced liver fibrosis in individuals at risk of steatotic liver disease.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Torgeir Gilje Lid

Research leader and professor of general practice

Helse Stavanger HF

研究点 (1)

Loading locations...

相似试验